Cost effectiveness of pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma: an economic evaluation of the PALM Trial.
about
Cost effectiveness of pegfilgrastim versus filgrastim after high-dose chemotherapy and autologous stem cell transplantation in patients with lymphoma and myeloma: an economic evaluation of the PALM Trial.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Cost effectiveness of pegfilgr ...... evaluation of the PALM Trial.
@en
Cost effectiveness of pegfilgr ...... evaluation of the PALM Trial.
@nl
type
label
Cost effectiveness of pegfilgr ...... evaluation of the PALM Trial.
@en
Cost effectiveness of pegfilgr ...... evaluation of the PALM Trial.
@nl
prefLabel
Cost effectiveness of pegfilgr ...... evaluation of the PALM Trial.
@en
Cost effectiveness of pegfilgr ...... evaluation of the PALM Trial.
@nl
P2093
P2860
P1476
Cost effectiveness of pegfilgr ...... evaluation of the PALM Trial.
@en
P2093
Aline Schmidt-Tanguy
Anne Lefranc
Bertrand Favier
Carole Siani
Catherine Sebban
Christian de Peretti
Daniel Espinouse
David Pérol
Fabrice Jardin
Lionel Perrier
P2860
P2888
P304
P356
10.1007/S40258-013-0011-7
P577
2013-04-01T00:00:00Z